Chronic pancreatitis (CP) is a chronic progressive inflammatory disease of the pancreas,
caused by multiple factors and accompanied by irreversible impairment of pancreatic …

Background Patients with acute pancreatitis (AP) have at least a 2-fold higher risk for
developing postpancreatitis diabetes mellitus (PPDM). No therapies have prevented PPDM …

Objectives The association between the use of statins and the incidence of acute
pancreatitis (AP) has yielded inconsistent findings. While statins have been implicated as an …

Objectives Quantify the risk of drug-induced pancreatitis (DIP) from angiotensin-converting
enzyme inhibitors (ACEis) and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors …

Background There is limited evidence on the role of chronic statin therapy in the prevention
of acute pancreatitis after ERCP. The aim of this meta-analysis was to evaluate the efficacy …

Background Post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
represents the most common serious complication after endoscopic retrograde …

摘要目的: 探讨加贝酯联合生长抑素治疗胰腺炎近期疗效及对炎症因子, D-乳酸的影响. 方法:
选择2017 年1 月至2010 年1 月在我院接受治疗的急性胰腺炎患者80 例为研究对象 …

Post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) represents the
most common serious complication after endoscopic retrograde cholangiopancreatography …

Endoscopic retrograde cholangiopancreatography (ERCP) is the first line therapy in many
pancreaticobiliary disorders. While highly effective, it can be technically challenging and is …

Background. Endoscopic retrograde cholangiopancreatography (ERCP) is an important
procedure in the diagnosis and management of pancreaticobiliary diseases. Post-ERCP …